Delivery Order SPE2DB22D3301-SPE2DB23FY6ML
Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,537.84, is for the delivery of 4,562,321,627 units of Naloxone 2 mg/2 ml syringes. The contract has a completion date of September 28, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a major...
- This federal contract award, valued at $1,537.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,321,657 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdoses. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,558,986,354 units of Naloxone HCL 4 mg nasal spray. The contract has a ceiling value of $11,337.85 and an ultimate completion date of November 4, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,537.84 firm fixed-price delivery order is for the supply of 4,562,321,631 units of 2 mg/2 ml naloxone syringes. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $1,239.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of Naloxone 2 mg/2 ml syringes, a critical medical product used in the treatment of opioid overdose. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Naloxone 2 mg/2 ml syringes. The $1,486.13 Firm Fixed Price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Naloxone 2 mg/2 ml syringes, with a ceiling value of $1,598.43 and a completion date of September 28, 2023. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense (DoD). The contract, with a ceiling value of $1,598.43, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,321,653 units of the pharmaceutical product Naloxone 2 mg/2 ml syringe, with an ultimate completion date of September 28, 2023. The contract...
- This federal contract award, valued at $1,053.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560979196 - Naloxone 2 mg/2 ml Syringes. This is a firm-fixed-price delivery order contract with a completion date of May 19, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $41,796.44 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4,563,589,049 units of Naloxone HCl 4 mg Nasal Spray. The Delivery Order has a period of performance through February 8, 2024 and uses a Firm Fixed Price pricing type. The contract was awarded on February 7, 2024 with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...